so we have been having this discussion over in another thread and as ive been saying for some time... there was the OG discussion with PA on another forum, in which he talked about how heavily aromatiazable trest is.. if you look at all the research you guys are parroting, trest isn't included in the research. Remember, trest is fairly new and the studies usually cited about 19 nors and no aromatization, are often quite old. anyhow, trest is an aromatase substrate, and the normal pathways for conversion are not needed. and there fore most AI do in fact have action in relation to trest..
there is some newer studies posted in other thread talking about trestolone specifically and how it aromatizes.,
and as a personally user I can tell you about an hr after administration, (im) I find my nipples will usually start to itch, so I take 1 mg of anastrozol and within a 20 min window the itching stops. yet if I avoid it, the nip will become very itchy and uncomfortable to the point I almost cant keep my jhands off them trying to scratch.
no im saying, from the research ive seen on trest specifically, multiple avenues are available for trest to convert and AIs do have appreciable effects on trests its ability to convert into estrogens.What are you saying? Trest is an aromatase substrate(the normal pathway), but the normal pathway isnt needed? So AI's which affect the normal pathway in the peripheral tissues shouldn't be useful in dealing with trestolone aromatization.
no im saying, from the research ive seen on trest specifically, multiple avenues are available for trest to convert and AIs do have appreciable effects on trests its ability to convert into estrogens.
im not saying everyone can get by with or with out one. everyone reacts differently to trest. I saw some one post they can run it with out any ancillaries, and anecdotally that's not the case for most.
This is why trestolone was abandoned, it causes an estrogen deficiency that leads to bone loss.
2kvette , how would you interpret the lab results of T. Huge after 100mg trest ace/d? Supposing they are real and no other aromatizing compound was used.
I'm with you and firmly believe that "trest gyno" is not estrogen related -but by prolactin/progesterone.
Invalid Link Removed
I'm currently using trest-ace without test, next week I'll stop using AI's, when test is out of my system -to prove the point that AI's do not work with trest (or at least , that it doesn't matter whether you take them -or not). I got gyno symptoms twice from trest in the past -but never used caber to curve prolactin, now I do.
By the way, the link to Tony's lab test is from xR1pp3Rx . It seems to demonstrate that trest heavily converts (aromatizes?) to a lab measurable estrogen (methyl estrogen?). If so -and if AI's do not curve the conversion, how does one control that much estrogen (SERM?).
Edit: 2kvette ,
Tony's lab test is showing ultra high estrogen, that would imply, that somehow methyl estrogen is not beneficial for bone density and is different from regular estrogen. If we assume all that, could we also assume that methyl estrogen may not cause gyno?
This study: Invalid Link Removed goes in depth at just how much trest can aromatize and how it is slow and inefficient. This is why trestolone was abandoned, it causes an estrogen deficiency that leads to bone loss.
The second pathway is effective, but aromatase inhibitors don't target it.
thanks for posting this, its an interesting read.. I did find one thing in the table shown, that the methylestradiol has the slowest rate of clearance across the board, so even though it (trest) has a slow and inefficient conversion via aromatse to m-est, the clearance rates might be whats causing the estro related sides for people.
again excellent find ~
thanks for posting this, its an interesting read.. I did find one thing in the table shown, that the methylestradiol has the slowest rate of clearance across the board, so even though it (trest) has a slow and inefficient conversion via aromatse to m-est, the clearance rates might be whats causing the estro related sides for people.
again excellent find ~
That is the big question! DOES ME indeed cause sides? Which? I assume bloat, is a given (high BP could be assumed as a consequence) -but how comes libido is high with high levels of ME?
I cant find relevant studies comparing estrogen to methyl estrogen, especially when it comes to controlling -or lowering it. Everything we do, like taking AI's and SERM's we do because others do.
7a MENT=27.5 min retention time vs 7aMethylEstradiol 33.5 mins respectively.Did you find the half life for 7ME? Because I can tell you just how much is building up by some math.
7-Methyl-Estradiol is 10% more potent than the normal estradiol that test converts to. And, as xR1pp3Rx just pointed out, has a slower clearance half life compared to normal estradiol. So its just a touch stronger than normal estrogen, and lasts longer in the system than normal estrogen. This explains everything reflected in his blood work.
But just a normal SERM will prevent the sides, AI won't prevent anything at all.
That is what all assume.
If its identical to estrogen -and even more potent, why doesn't libido suffer with high ME? But suffer greatly when estrogen is high?
b/c your taking trest with it. Trest has 5x the androgenic (sexual) gene expression effects of testosterone. So its potent at counteracting this. And high estrogen doesnt kill sex drive a lot of times, but low E does. I've been on both sides of this coin and my dick will take high E any day.
I know this is a three year old thread, but had to throw this in here. True progestins can’t aromatize. Nandrolone is both a androgen and progestin. It has minimal if any aromatization. Trestolone though also a 19 NOR aromatizes quite heavily. It aromatizes into the potent methyl estradiol.NPP can't aromatize, no progestin can, there is no such thing as nor estrogen, all estrogens are carbon 19 absent. The gyno comes from increased fluid retention that is tissue specific b/c 19-nor steroids will bind and activate the progesterone receptor.
NPP can't aromatize, no progestin can, there is no such thing as nor estrogen, all estrogens are carbon 19 absent. The gyno comes from increased fluid retention that is tissue specific b/c 19-nor steroids will bind and activate the progesterone receptor.
Part of the biological effects of testosterone (T) are mediated by its enzymatic reduction to 5 alpha-dihydrotestosterone (DHT) or aromatization to estradiol (E2). 7 alpha-Methyl-19-nortestosterone (MENT) is a synthetic androgen that is considerably more potent than T. Previous studies have shown that MENT is not 5 alpha-reduced. The studies reported here were undertaken to determine whether MENT undergoes enzymatic aromatization in vitro. Human placental microsomes were used as the source of the aromatase. Radioactive or nonradioactive T or MENT was incubated with the microsomes in the presence of NADPH and the metabolites extracted out with ethyl ether. Following evaporation of ether, the residue was dissolved in benzene-petroleum ether and extracted with 0.4 N NaOH which selectively removes phenolic metabolites of the androgens. When either radioactive T or MENT was incubated with the aromatase in the presence of NADPH, there was a 20-fold increase in the amount of radioactivity extracted with NaOH. In contrast, if the incubation was carried out in the absence of NADPH or in the presence of R76713, an aromatase inhibitor, most of the radioactivity remained in the benzene-petroleum ether phase. To further identify the enzymatic reaction products, thin layer chromatography (TLC) was performed. The Rf value for MENT was 0.22 while that of the major reaction product was 0.34, which corresponded with the RF value of the estrogen, 7 alpha-methyl-estradiol (MeE2). This was further verified by using a second solvent system for the chromatographic separation. In an effort to ascertain whether the metabolites bind to estrogen receptors (ER), rat uterine cytosol was used. NaOH extracts of medium following incubation of nonradioactive MENT with microsomes showed competitive inhibition of [3H]E2 binding to rat uterine ER. Furthermore, after [3H]MENT was incubated with microsomes, the radioactive metabolite extracted in NaOH showed specific binding to the ER which could readily be displaced with E2 or MeE2. These results indicate that like T, MENT undergoes enzymatic aromatization.NPP can't aromatize, no progestin can, there is no such thing as nor estrogen, all estrogens are carbon 19 absent. The gyno comes from increased fluid retention that is tissue specific b/c 19-nor steroids will bind and activate the progesterone receptor.
Correct. They do not aromatize via the aromatase enzyme. They do it via a different enzyme that is specific to the liver.ACTUALLY. its been found that 19 nors can and do readily aromatize through different pathways. mainly in the liver.
ACTUALLY. its been found that 19 nors can and do readily aromatize through different pathways. mainly in the liver.
Since we're talking so much about trest, I actually stumbled across this while looking for something else:
Invalid Link Removed
Invalid Link Removed
Invalid Link Removed
Hopefully spomeone'll find these useful.